Annual Cash & Cash Equivalents
$33.49 M
+$19.48 M+139.03%
December 31, 2023
Summary
- As of February 8, 2025, TOI annual cash & cash equivalents is $33.49 million, with the most recent change of +$19.48 million (+139.03%) on December 31, 2023.
- During the last 3 years, TOI annual cash & cash equivalents has risen by +$27.49 million (+458.32%).
- TOI annual cash & cash equivalents is now -70.70% below its all-time high of $114.30 million, reached on December 31, 2021.
Performance
TOI Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$47.40 M
+$10.98 M+30.14%
September 30, 2024
Summary
- As of February 8, 2025, TOI quarterly cash and cash equivalents is $47.40 million, with the most recent change of +$10.98 million (+30.14%) on September 30, 2024.
- Over the past year, TOI quarterly cash and cash equivalents has increased by +$11.35 million (+31.47%).
- TOI quarterly cash and cash equivalents is now -58.53% below its all-time high of $114.30 million, reached on December 31, 2021.
Performance
TOI Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TOI Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +139.0% | +31.5% |
| 3 y3 years | +458.3% | -26.2% |
| 5 y5 years | +1269.0% | -26.2% |
TOI Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -70.7% | +139.0% | -58.5% | +238.3% |
| 5 y | 5-year | -70.7% | +1269.0% | -58.5% | +690.3% |
| alltime | all time | -70.7% | +1269.0% | -58.5% | +690.3% |
Oncology Institute Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $47.40 M(+30.1%) |
| Jun 2024 | - | $36.42 M(+1.0%) |
| Mar 2024 | - | $36.05 M(+7.7%) |
| Dec 2023 | $33.49 M(+139.0%) | $33.49 M(+21.6%) |
| Sep 2023 | - | $27.54 M(-4.7%) |
| Jun 2023 | - | $28.89 M(+89.5%) |
| Mar 2023 | - | $15.25 M(+8.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $14.01 M(-87.7%) | $14.01 M(-77.2%) |
| Sep 2022 | - | $61.42 M(-4.3%) |
| Jun 2022 | - | $64.21 M(-32.2%) |
| Mar 2022 | - | $94.66 M(-17.2%) |
| Dec 2021 | $114.30 M(+1805.6%) | $114.30 M(+653.5%) |
| Jun 2021 | - | $15.17 M(+152.9%) |
| Dec 2020 | $6.00 M(+145.2%) | $6.00 M |
| Dec 2019 | $2.45 M | - |
FAQ
- What is Oncology Institute annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Oncology Institute?
- What is Oncology Institute annual cash & cash equivalents year-on-year change?
- What is Oncology Institute quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Oncology Institute?
- What is Oncology Institute quarterly cash and cash equivalents year-on-year change?
What is Oncology Institute annual cash & cash equivalents?
The current annual cash & cash equivalents of TOI is $33.49 M
What is the all time high annual cash & cash equivalents for Oncology Institute?
Oncology Institute all-time high annual cash & cash equivalents is $114.30 M
What is Oncology Institute annual cash & cash equivalents year-on-year change?
Over the past year, TOI annual cash & cash equivalents has changed by +$19.48 M (+139.03%)
What is Oncology Institute quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TOI is $47.40 M
What is the all time high quarterly cash and cash equivalents for Oncology Institute?
Oncology Institute all-time high quarterly cash and cash equivalents is $114.30 M
What is Oncology Institute quarterly cash and cash equivalents year-on-year change?
Over the past year, TOI quarterly cash and cash equivalents has changed by +$11.35 M (+31.47%)